Indoco Remedies Share Price

Indoco Remedies Share Price

NSE: INDOCO
|
Pharmaceuticals
|
S Cap
₹ 272.56
-₹1.21 (-0.44%)
1D
Last updated 03 Sep, 2026, 15:57 IST

Indoco Remedies Share Price Today

As of 3 Sep 2026, Indoco Remedies share price is ₹272.56. The stock opened at ₹273.36, compared to its previous close of ₹273.77. During today's trading session, Indoco Remedies share price moved in the range of ₹266.38 to ₹283.50, with an average price of ₹274.94 for the day. Looking at its last 52-week, the stock has touched a low of ₹162.19 and a high of ₹332.20. On the performance front, Indoco Remedies share price has increased by 36.40% over the last six months and is down 0.70% on a year-on-year basis.

₹266.38
0.44% down today
₹283.50
1D LOW
1D HIGH

Indoco Remedies Returns Calculator

Circuit
L
H
₹219.02
₹328.52
52-week
L
H
₹162.19
₹332.20

About Indoco Remedies

Indoco Remedies Share Price
ISIN
INE873D01024
Sector Market Cap
₹ 2,526.81 Cr

Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.

Indoco Remedies Financial Highlights

  • Revenue: Indoco Remedies reported revenue of ₹1,848.65 crore in FY26 vs ₹1,670.37 crore in FY25. It showed an increase of 10.67% on a yearly basis.
  • Operating Profit: Indoco Remedies reported an operating loss of ₹106.51 crore in FY26 vs ₹74.37 crore in FY25. It showed a decrease of 43.22% on a year-on-year basis.
  • Net Profit: Indoco Remedies reported a net loss of ₹98.70 crore in FY26 vs ₹77.95 crore in FY25. It showed a decrease of 26.62% on a yearly basis.

Indoco Remedies Quarterly Result Highlights

  • Indoco Remedies reported revenue of ₹469.68 crore in Jun 2026, compared with ₹475.57 crore in Mar 2026, representing a decrease of 1.24% on a quarter-on-quarter (QoQ) basis.
  • Indoco Remedies reported an operating profit of ₹77.72 crore in Jun 2026, compared with ₹25.00 crore in Mar 2026, representing an increase of 410.88% on a quarter-on-quarter (QoQ) basis.
  • Indoco Remedies reported a profit of ₹65.44 crore in Jun 2026, compared with ₹23.68 crore in Mar 2026, reflecting an increase of 376.35% on a QoQ basis.
  • The earnings per share (EPS) of Indoco Remedies stood at ₹10.70 during Jun 2026.
Know more
Promoters
58.86%
FII
1.27%
Other DII
0.52%
Retail and other
22.18%
Mutual funds
17.16%
Foreign institutions - FII
FII shareholding by period
Sep 20251.25%
Dec 20251.10%
Mar 20260.94%
Jun 20261.27%
Mkt Cap Cr
2,526.81
P/E
805.15
P/B
2.69
ROE
-10.13%
D/E
0.69
ROCE
0.77%
Div. Yield
0.07%
EPS(TTM)
-0.61
Turnover
0.70
EV/EBITDA
12.55
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.12%
Quick Ratio
0.00
Curr. Ratio
2.42
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Indoco Remedies outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Indoco Remedies appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Indoco Remedies earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,791.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,45,081.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,90,351.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,14,833.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,163.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,431.0017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma98,304.7047.546.0311.74%0.3413.13%396.980.04%0.4449.37
Aurobindo Pharma95,299.8025.682.529.25%0.1911.76%394.820.24%0.3841.58

Indoco Remedies Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,845.32₹1,664.92₹1,817.29₹1,668.61
Other Income₹3.33₹5.45₹9.85₹2.34
Total Revenue₹1,848.65₹1,670.37₹1,827.13₹1,670.95
Total Expenses₹1,952.20₹1,745.74₹1,702.86₹1,478.15
Profit Before Tax-₹106.50-₹74.37₹135.80₹192.79
Tax-₹7.81₹3.58₹38.79₹50.54
Profit After Tax-₹98.68-₹77.95₹97.00₹142.25
EPS - Basic-₹10.70-₹8.46₹10.53₹15.44
EPS - Diluted-₹10.69-₹8.45₹10.51₹15.42

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹103.55-₹75.36₹124.27₹192.79
Income before WC changes₹146.43₹108.27₹261.82₹313.67
Change in Assets-₹165.78-₹48.15-₹145.24-₹61.45
Change in Liabilities₹220.69₹50.94₹58.07-₹11.74
Change in WC₹54.91₹2.79-₹87.16-₹73.19
Cash flow from Operations₹192.23₹94.94₹156.70₹178.83
Cash flow from Investing-₹101.61-₹339.11-₹433.83-₹208.17
Cash flow from Financing-₹76.79₹241.42₹280.43₹22.80
Total Cash Flow₹13.82-₹2.75₹3.31-₹6.54
Cash (Start of the year)₹12.11₹14.86₹10.92₹17.47
Cash (End of the year)₹25.93₹12.11₹14.86₹10.92

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,399.91₹1,428.57₹1,190.06₹844.63
Current Assets₹1,193.35₹1,001.35₹954.67₹813.57
Total Assets₹2,593.27₹2,429.91₹2,144.73₹1,658.20
Current Liabilities₹1,052.54₹807.99₹612.33₹424.51
Net Current Asset₹140.81₹193.35₹342.34₹389.06
Non-Current Liabilities₹608.61₹603.54₹421.90₹205.44
Equity Capital₹932.11₹1,018.38₹1,110.50₹1,028.25
Total Equity & Liabilities₹2,593.27₹2,429.91₹2,144.73₹1,658.20

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,686.07₹1,518.19₹1,790.81₹1,666.69
Other Income₹29.64₹18.48₹8.51₹2.33
Total Revenue₹1,715.71₹1,536.67₹1,799.32₹1,669.02
Total Expenses₹1,724.30₹1,545.04₹1,657.62₹1,477.43
Profit Before Tax-₹11.45-₹7.38₹153.23₹191.59
Tax-₹5.82₹1.36₹36.58₹50.23
Profit After Tax-₹5.63-₹8.74₹116.64₹141.36
EPS - Basic-₹0.61-₹0.95₹12.66₹15.34
EPS - Diluted-₹0.61-₹0.95₹12.64₹15.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹8.59-₹8.37₹141.70₹191.59
Income before WC changes₹169.59₹138.85₹271.78₹312.47
Change in Assets-₹156.70-₹36.94-₹95.81-₹61.47
Change in Liabilities₹222.25₹21.05₹18.39-₹10.82
Change in WC₹65.55-₹15.89-₹77.42-₹72.29
Cash flow from Operations₹226.35₹107.36₹176.78₹178.79
Cash flow from Investing-₹87.38-₹276.39-₹301.70-₹208.51
Cash flow from Financing-₹133.09₹168.62₹122.40₹22.81
Total Cash Flow₹5.87-₹0.41-₹2.52-₹6.91
Cash (Start of the year)₹7.06₹7.47₹9.99₹16.90
Cash (End of the year)₹12.94₹7.06₹7.47₹9.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,251.39₹1,262.28₹1,060.39₹847.21
Current Assets₹1,113.72₹938.88₹900.21₹812.47
Total Assets₹2,365.11₹2,201.16₹1,960.61₹1,659.67
Current Liabilities₹875.47₹695.01₹562.25₹427.24
Net Current Asset₹238.24₹243.87₹337.96₹385.23
Non-Current Liabilities₹390.44₹402.79₹271.74₹205.41
Equity Capital₹1,099.19₹1,103.36₹1,126.62₹1,027.02
Total Equity & Liabilities₹2,365.11₹2,201.16₹1,960.61₹1,659.67
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
272.56
2917
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2917
Buy orders: 0%
Sell orders: 100%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
73.96
Bullish
ATR (14)
12.24
Neutral
STOCH(9,6)
80.46
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
36.76
Bearish
UO(9)
62.41
Neutral
ROC(12)
25.16
Bullish
WillR(14)
-19.34
Bearish
Period
Simple value
Exponential vaue
5D
250.46
252.07
10D
238.47
242.76
20D
229.13
235.77
50D
235.12
231.5
100D
226.12
227.19
Volume trend — traded volume by day
3 Sep14L
2 Sep1Cr
1 Sep0L
31 Aug1L
28 Aug2L
27 Aug1L
Average35L
Compare against other stocks
Indoco Remedies Share Price
Indoco Remedies
Pharmaceuticals
Add Stock
Add Another

Indoco Remedies Share Price FAQs